Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Juan Carlos García-Pagán
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Physiology
Chemicals & Drugs
Anatomy
Procedures
Living Beings
Sign-in to see full Profile
Network (preview)
91
Bosch, Jaime
49
Rodés, Juan
34
Feu, Faust
29
Escorsell, Angels
18
Abraldes, Juan
18
Moitinho, Eduardo
13
Gilabert, Rosa
12
Navasa, Miquel
10
Bordas, Josep
10
Bañares, Rafael
10
Bandi, JC
9
Turnes, Juan
7
Rodríguez-Vilarrupla, Aina
7
Graupera, Mariona
7
Piqué, Josep
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Juan Carlos García-Pagán (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: La Mura Vincenzo; Abraldes Juan G; Raffa Sebastian; Retto Oswaldo; Berzigotti Annalisa; García-Pagán Juan Carlos; Bosch Jaume
Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
Journal of hepatology 2009;51(2):279-87.
-
2009: Dominguez Marlene; Miquel Rosa; Colmenero Jordi; Moreno Montserrat; García-Pagán Joan-Carles; Bosch Jaime; Arroyo Vicente; Ginès Pere; Caballería Juan; Bataller Ramón
Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.
Gastroenterology 2009;136(5):1639-50.
-
2009: Abraldes Juan G; Albillos Agustin; Bañares Rafael; Turnes Juan; González Rosario; García-Pagán Juan Carlos; Bosch Jaime
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Gastroenterology 2009;136(5):1651-8.
-
2008: Dominguez Marlene; Rincón Diego; Abraldes Juan G; Miquel Rosa; Colmenero Jordi; Bellot Pablo; García-Pagán Joan-Carles; Fernández Rosamelia; Moreno Montserrat; Bañares Rafael; Arroyo Vicente; Caballería Joan; Ginès Pere; Bataller Ramón
A new scoring system for prognostic stratification of patients with alcoholic hepatitis.
The American journal of gastroenterology 2008;103(11):2747-56.
-
2008: Berzigotti A; García-Pagán J C
Prevention of recurrent variceal bleeding.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2008;40(5):337-42.
-
2008: Rodríguez-Vilarrupla Aina; Graupera Mariona; Matei Vasilica; Bataller Ramón; Abraldes Juan G; Bosch Jaume; García-Pagán Joan-Carles
Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(4):566-73.
-
2008: Gracia-Sancho Jorge; Laviña Bàrbara; Rodríguez-Vilarrupla Aina; García-Calderó Héctor; Fernández Mercedes; Bosch Jaume; García-Pagán Joan-Carles
Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability.
Hepatology (Baltimore, Md.) 2008;47(4):1248-56.
-
2008: González-Navajas José M; Bellot Pablo; Francés Rubén; Zapater Pedro; Muñoz Carlos; García-Pagán Juan Carlos; Pascual Sonia; Pérez-Mateo Miguel; Bosch Jaime; Such José
Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin.
Journal of hepatology 2008;48(1):61-7.
-
2007: Gracia-Sancho Jorge; Laviña Bàrbara; Rodríguez-Vilarrupla Aina; Brandes Ralf P; Fernández Mercedes; Bosch Jaume; García-Pagán Joan-Carles
Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.
Gastroenterology 2007;133(3):959-66.
-
2007: Gracia-Sancho Jorge; Laviña Bàrbara; Rodríguez-Vilarrupla Aina; García-Calderó Héctor; Bosch Jaime; García-Pagán Joan Carles
Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers.
Journal of hepatology 2007;47(2):220-7.
-
2007: Abraldes Juan G; Rodríguez-Vilarrupla Aina; Graupera Mariona; Zafra Carmen; García-Calderó Héctor; García-Pagán Juan Carlos; Bosch Jaime
Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.
Journal of hepatology 2007;46(6):1040-6.
-
2007: Rodríguez-Vilarrupla Aina; Bosch Jaume; García-Pagán Joan-Carles
Potential role of antioxidants in the treatment of portal hypertension.
Journal of hepatology 2007;46(2):193-7.
-
2007: García-Pagán Juan Carlos; Bellot García Pablo; Bosch Genover Jaime
[Endoscopic ligature of esophageal varices in the treatment of portal hypertension]
Revista de gastroenterología de México 2007;72(1):52-61.
-
2007: Rodríguez-Vilarrupla Aina; Fernández Mercedes; Bosch Jaume; García-Pagán Joan Carles
Current concepts on the pathophysiology of portal hypertension.
Annals of hepatology : official journal of the Mexican Association of Hepatology 2007;6(1):28-36.
-
2006: García-Pagán Juan Carlos
[Covered transjugular intrahepatic portosystemic shunts]
Gastroenterología y hepatología 2006;29(10):647-51.
-
2006: García-Pagán Juan Carlos; Calleja José Luis; Bañares Rafael
[Liver diseases.]
Gastroenterología y hepatología 2006;29 Suppl 3():99-111.
-
2006: Abraldes Juan-G; Pasarín Marcos; García-Pagán Juan-Carlos
Animal models of portal hypertension.
World journal of gastroenterology : WJG 2006;12(41):6577-84.
-
2006: Bargalló Xavier; Gilabert Rosa; Nicolau Carlos; García-Pagán Juan Carlos; Ayuso Juan Ramón; Brú Concepció
Sonography of Budd-Chiari syndrome.
AJR. American journal of roentgenology 2006;187(1):W33-41.
-
2006: Conget Ignacio; Piquer Sandra; Julià Marta; Gomis Ramón; Esmatjes Enric; García-Pagán Juan Carlos; Bosch Jaume; Gilabert Rosa; Ricart Maria Jose; Fernández-Cruz Laureano; Manyalich Marti
Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route.
Transplantation 2006;81(8):1220-1.
-
2006: Mínguez Beatriz; García-Pagán Juan Carlos; Bosch Jaume; Turnes Juan; Alonso Juli; Rovira Alex; Córdoba Juan
Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
Hepatology (Baltimore, Md.) 2006;43(4):707-14.
-
2006: Blasco Alejandro; Forns Xavier; Carrión José A; García-Pagán Juan Carlos; Gilabert Rosa; Rimola Antoni; Miquel Rosa; Bruguera Miquel; García-Valdecasas Juan-Carlos; Bosch Jaime; Navasa Miquel
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.
Hepatology (Baltimore, Md.) 2006;43(3):492-9.
-
2006: Hernández-Guerra Manuel; García-Pagán Juan C; Turnes Juan; Bellot Pablo; Deulofeu Ramón; Abraldes Juan G; Bosch Jaime
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
Hepatology (Baltimore, Md.) 2006;43(3):485-91.
-
2006: Abraldes J G; García-Pagán J C
[Animal models for the study of portal hypertension]
Gastroenterología y hepatología 2006;29(1):51-9.
-
2006: Turnes Juan; Hernández-Guerra Manuel; Abraldes Juan G; Bellot Pau; Oliva Rafael; García-Pagán Juan Carlos; Bosch Jaime
Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
Hepatology (Baltimore, Md.) 2006;43(1):34-41.
-
2006: Hernández-Guerra Manuel; López Eric; Bellot Pablo; Piera Carlos; Turnes Juan; Abraldes Juan G; Bosch Jaime; García-Pagán Juan C
Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome.
Hepatology (Baltimore, Md.) 2006;43(1):27-33.
-
2005: Abraldes Juan G; Gilabert Rosa; Turnes Juan; Nicolau Carles; Berzigotti Annalisa; Aponte John; Bru Concepció; Bosch Jaime; García-Pagán Juan Carlos
Utility of color Doppler ultrasonography predicting tips dysfunction.
The American journal of gastroenterology 2005;100(12):2696-701.
-
2005: Dell'Era Alessandra; Grande Luis; Barros-Schelotto Pablo; Turnes Juan; Fuster Josep; Charco Ramón; García-Valdecasas Juan-Carlos; Bosch Jaime; García-Pagán Juan-Carlos
Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
Surgery 2005;137(6):620-5.
-
2005: Hernández-Guerra Manuel; García-Pagán Juan Carlos; Bosch Jaime
Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension.
Journal of clinical gastroenterology 2005;39(4 Suppl 2):S131-7.
-
2005: Graupera Mariona; March Sandra; Engel Pablo; Rodés Juan; Bosch Jaume; García-Pagán Joan-Carles
Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.
American journal of physiology. Gastrointestinal and liver physiology 2005;288(4):G763-70.
-
2004: Hernández-Guerra Manuel; Turnes Juan; Rubinstein Pablo; Olliff Simon; Elias Elwyn; Bosch Jaime; García-Pagán Juan Carlos
PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.
Hepatology (Baltimore, Md.) 2004;40(5):1197-202.
-
2004: Hernández-Guerra M; García-Pagán J C;
[Recommendations for the diagnosis and treatment of patients with Budd-Chiari syndrome]
Gastroenterología y hepatología 2004;27(8):473-9.
-
2004: Abraldes J G; García-Pagán J C; Bosch J
[Functional component of portal hypertension]
Gastroenterología y hepatología 2004;27(6):377-87.
-
2004: Bouza Emilio; Muñoz Patricia; Rodríguez Claudia; Grill Fabio; Rodríguez-Créixems Marta; Bañares Rafael; Fernández Javier; García-Pagán Juan Carlos
Endotipsitis: an emerging prosthetic-related infection in patients with portal hypertension.
Diagnostic microbiology and infectious disease 2004;49(2):77-82.
-
2004: García-Pagán Juan Carlos; Bosch Jaume
The resistance of the cirrhotic liver: a new target for the treatment of portal hypertension. 1985.
Journal of hepatology 2004;40(6):887-90.
-
2004: Alvarez-Larrán Alberto; García-Pagán Juan Carlos; Abraldes Juan G; Arellano Eduardo; Reverter Juan Carlos; Bosch Jaume; Cervantes Francisco
Increased CD11b neutrophil expression in Budd-Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera.
British journal of haematology 2004;124(3):329-35.
-
2003: Bargalló Xavier; Gilabert Rosa; Nicolau Carlos; García-Pagán Juan Carlos; Bosch Jaume; Brú Concepció
Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome.
AJR. American journal of roentgenology 2003;181(6):1641-5.
-
2003: Graupera Mariona; García-Pagán Joan-Carles; Parés Mireia; Abraldes Juan G; Roselló Joan; Bosch Jaume; Rodés Juan
Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers.
Journal of hepatology 2003;39(4):515-21.
-
2003: García-Pagán Juan Carlos; Morillas Rosa; Bañares Rafael; Albillos Agustin; Villanueva Candido; Vila Carme; Genescà Joan; Jimenez Manuel; Rodriguez Manuel; Calleja Jose Luis; Balanzó Joaquin; García-Durán Fernando; Planas Ramón; Bosch Jaume;
Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.
Hepatology (Baltimore, Md.) 2003;37(6):1260-6.
-
2003: Bosch Jaume; García-Pagán Juan Carlos
Prevention of variceal rebleeding.
Lancet 2003;361(9361):952-4.
-
2003: Bellis Lia; Berzigotti Annalisa; Abraldes Juan G; Moitinho Eduardo; García-Pagán Juan C; Bosch Jaime; Rodés Juan
Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
Hepatology (Baltimore, Md.) 2003;37(2):378-84.
-
2003: Graupera Mariona; García-Pagán Joan-Carles; Abraldes Juan G; Peralta Carmen; Bragulat Mireia; Corominola Helena; Bosch Jaume; Rodés Juan
Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.
Hepatology (Baltimore, Md.) 2003;37(1):172-81.
-
2003: Bellis L; Moitinho E; Abraldes J G; Graupera M; García-Pagán J C; Rodés J; Bosch J
Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shunt.
Gut 2003;52(1):130-3.
-
2002: González-Abraldes Juan; García-Pagán Juan Carlos; Bosch Jaime
Nitric oxide and portal hypertension.
Metabolic brain disease 2002;17(4):311-24.
-
2002: Bañares Rafael; Moitinho Eduardo; Matilla Ana; García-Pagán Juan Carlos; Lampreave José Luis; Piera Carlos; Abraldes Juan G; De Diego Alejandro; Albillos Agustín; Bosch Jaime
Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
Hepatology (Baltimore, Md.) 2002;36(6):1367-73.
-
2002: Escorsell Angels; Ginès Angels; Llach Josep; García-Pagán Joan C; Bordas Josep M; Bosch Jaume; Rodés Joan
Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices.
Hepatology (Baltimore, Md.) 2002;36(4 Pt 1):936-40.
-
2002: Andreu Victoria; Perello Antonia; Moitinho Eduardo; Escorsell Angels; García-Pagán Juan-Carlos; Bosch Jaume; Rodés Joan
Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.
Journal of hepatology 2002;36(3):356-61.
-
2002: Graupera Mariona; García-Pagán Juan-Carlos; Titos Esther; Claria Joan; Massaguer Anna; Bosch Jaime; Rodés Juan
5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes.
Gastroenterology 2002;122(2):387-93.
-
2002: Escorsell Angels; Bañares Rafael; García-Pagán Juan Carlos; Gilabert Rosa; Moitinho Eduardo; Piqueras Belén; Bru Concepció; Echenagusia Antonio; Granados Alicia; Bosch Jaume
TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.
Hepatology (Baltimore, Md.) 2002;35(2):385-92.
-
2002: Perelló Antonia; García-Pagán Juan Carlos; Gilabert Rosa; Suárez Yanette; Moitinho Eduardo; Cervantes Francisco; Reverter Juan Carlos; Escorsell Angels; Bosch Jaume; Rodés Juan
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.
Hepatology (Baltimore, Md.) 2002;35(1):132-9.
-
2001: González-Abraldes J; Bosch J; García-Pagán J C
Pharmacological treatment of portal hypertension.
Current opinion in investigational drugs (London, England : 2000) 2001;2(10):1407-13.
-
2001: García-Pagán J C; Villanueva C; Vila M C; Albillos A; Genescà J; Ruiz-Del-Arbol L; Planas R; Rodriguez M; Calleja J L; González A; Solà R; Balanzó J; Bosch J;
Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers.
Gastroenterology 2001;121(4):908-14.
-
2001: González-Abraldes J; Albillos A; Bañares R; Del Arbol L R; Moitinho E; Rodríguez C; González M; Escorsell A; García-Pagán J C; Bosch J
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.
Gastroenterology 2001;121(2):382-8.
-
2001: Turnes J; García-Pagán J C; González-Abraldes J; Real M; Moitinho E; Gilabert R; Escorsell A; Muntanya X; Ginès P; Bosch J; Rodés J
Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2001;7(7):649-51.
-
2001: González-Abraldes J; Moitinho E; García-Pagán J C; Escorsell A; Salmerón J M; Gilabert R; Real M; Muntanyá X; Bosch J
Selective arterial embolization for life threatening hemobilia after transjugular intrahepatic portosystemic shunt placement.
Journal of hepatology 2001;34(1):174-6.
-
2001: Escorsell A; Bandi J C; Andreu V; Moitinho E; García-Pagán J C; Bosch J; Rodés J
Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.
Gastroenterology 2001;120(1):161-9.
-
2000: García-Pagán J C; Perelló A; Bosch J
[Budd-Chiari syndrome]
Gastroenterología y hepatología 2000;23(10):491-7.
-
2000: García-Pagán J C; Bosch J
Medical treatment of portal hypertension.
Baillière's best practice & research. Clinical gastroenterology 2000;14(6):895-909.
-
2000: Debernardi-Venon W; Bandi J C; García-Pagán J C; Moitinho E; Andreu V; Real M; Escorsell A; Montanyá X; Bosch J
CO(2) wedged hepatic venography in the evaluation of portal hypertension.
Gut 2000;46(6):856-60.
-
2000: Escorsell A; Bordas J M; Castañeda B; Llach J; García-Pagán J C; Rodés J; Bosch J
Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.
Hepatology (Baltimore, Md.) 2000;31(5):1061-7.
-
2000: Cirera I; Navasa M; Rimola A; García-Pagán J C; Grande L; Garcia-Valdecasas J C; Fuster J; Bosch J; Rodes J
Ascites after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000;6(2):157-62.
-
1999: Perelló A; Escorsell A; Bru C; Gilabert R; Moitinho E; García-Pagán J C; Bosch J
Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis.
Hepatology (Baltimore, Md.) 1999;30(6):1393-7.
-
1999: Luca A; García-Pagán J C; de Lacy A M; Escorsell A; Feu F; Visa J; Bosch J; Rodés J
Effects of end-to-side portacaval shunt and distal splenorenal shunt on systemic and pulmonary haemodynamics in patients with cirrhosis.
Journal of gastroenterology and hepatology 1999;14(11):1112-8.
-
1999: Bandi J C; Fernández M; Bernadich C; De Lacy A M; García-Pagán J C; Bosch J; Rodés J
Hyperkinetic circulation and decreased sensitivity to vasoconstrictors following portacaval shunt in the rat. Effects of chronic nitric oxide inhibition.
Journal of hepatology 1999;31(4):719-24.
-
1999: Moitinho E; Escorsell A; Bandi J C; Salmerón J M; García-Pagán J C; Rodés J; Bosch J
Prognostic value of early measurements of portal pressure in acute variceal bleeding.
Gastroenterology 1999;117(3):626-31.
-
1999: Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán J C; de Diego A; Bosch J
Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1999;30(1):79-83.
-
1999: García-Pagán J C; Escorsell A; Moitinho E; Bosch J
Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension.
Seminars in liver disease 1999;19(4):427-38.
-
1998: Elizalde J I; Moitinho E; García-Pagán J C; Cirera I; Escorsell A; Bandi J C; Jiménez W; Bosch J; Piqué J M; Rodés J
Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients.
Journal of hepatology 1998;29(5):789-95.
-
1998: Bandi J C; García-Pagán J C; Escorsell A; François E; Moitinho E; Rodés J; Bosch J
Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1998;28(3):677-82.
-
1998: Albillos A; García-Pagán J C; Iborra J; Bandi J C; Cacho G; Pérez-Paramo M; Escorsell A; Calleja J L; Escartín P; Bosch J
Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
Gastroenterology 1998;115(1):116-23.
-
1998: Casado M; Bosch J; García-Pagán J C; Bru C; Bañares R; Bandi J C; Escorsell A; Rodríguez-Láiz J M; Gilabert R; Feu F; Schorlemer C; Echenagusia A; Rodés J
Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings.
Gastroenterology 1998;114(6):1296-303.
-
1997: Bandi J C; Poch E; García-Pagán J C; Luca A; Jiménez W; Escorsell A; Rodés J
Platelet cytosolic calcium concentration in patients with liver cirrhosis. Relationship with hepatic and systemic hemodynamics.
Journal of hepatology 1997;27(5):824-9.
-
1997: Escorsell A; Bordas J M; Feu F; García-Pagán J C; Ginès A; Bosch J; Rodés J
Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.
Gastroenterology 1997;113(5):1640-6.
-
1997: García-Pagán J C; Bosch J
Pharmacological prevention of variceal bleeding. New developments.
Baillière's clinical gastroenterology 1997;11(2):271-87.
-
1997: Escorsell A; Ferayorni L; Bosch J; García-Pagán J C; García-Tsao G; Grace N D; Rodés J; Groszmann R J
The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than in those with varices.
Gastroenterology 1997;112(6):2012-6.
-
1997: Luca A; García-Pagán J C; Bosch J; Feu F; Caballería J; Groszmann R J; Rodés J
Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis.
Gastroenterology 1997;112(4):1284-9.
-
1997: François E; García-Pagán J C; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
[Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension]
Gastroenterología y hepatología 1997;20(1):1-4.
-
1996: Trejo R; Alvarez W; García-Pagán J C; Feu F; Escorsell A; Bruguera M; Bosch J; Rodés J
[The applicability and diagnostic effectiveness of transjugular liver biopsy]
Medicina clínica 1996;107(14):521-3.
-
1996: Fernández M; García-Pagán J C; Casadevall M; Mourelle M I; Piqué J M; Bosch J; Rodés J
Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis.
Gastroenterology 1996;110(5):1529-35.
-
1996: García-Pagán J C; Escorsell A; Feu F; Bandi J C; Moitinho E; Casado M; Bosch J; Rodés J
Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
Journal of hepatology 1996;24(4):430-5.
-
1996: Escorsell A; Feu F; Bordas J M; García-Pagán J C; Luca A; Bosch J; Rodés J
Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Journal of hepatology 1996;24(4):423-9.
-
1996: Llach J; Bordas J M; Salmerón J M; Panés J; García-Pagán J C; Feu F; Navasa M; Mondelo F; Piqué J M; Mas A; Terés J; Rodés J
A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage.
Gastrointestinal endoscopy 1996;43(2 Pt 1):117-20.
-
1995: Feu F; García-Pagán J C; Bosch J; Luca A; Terés J; Escorsell A; Rodés J
Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.
Lancet 1995;346(8982):1056-9.
-
1995: Luca A; García-Pagán J C; Bosch J; Feu F; Jiménez W; Ginés A; Fernández M; Escorsell A; Arroyo V; Rodés J
Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.
Hepatology (Baltimore, Md.) 1995;22(3):753-8.
-
1995: Cirera I; Feu F; Luca A; García-Pagán J C; Fernández M; Escorsell A; Bosch J; Rodés J
Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
Hepatology (Baltimore, Md.) 1995;22(1):106-11.
-
1995: García-Pagán J C; Bosch J; Rodés J
The role of vasoactive mediators in portal hypertension.
Seminars in gastrointestinal disease 1995;6(3):140-7.
-
1995: Fernández M; García-Pagán J C; Casadevall M; Bernadich C; Piera C; Whittle B J; Piqué J M; Bosch J; Rodés J
Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.
Gastroenterology 1995;108(5):1487-95.
-
1995: Luca A; García-Pagán J C; Feu F; Lopez-Talavera J C; Fernández M; Bru C; Bosch J; Rodés J
Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1995;21(1):83-8.
-
1994: Morillas R M; Planas R; Cabré E; Galán A; Quer J C; Feu F; García Pagán J C; Bosch J; Gassull M A
Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
Hepatology (Baltimore, Md.) 1994;20(6):1502-8.
-
1994: García-Pagán J C; Fernández M; Bernadich C; Pizcueta P; Piqué J M; Bosch J; Rodés J
Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.
The American journal of physiology 1994;267(6 Pt 1):G984-90.
-
1994: Luca A; Feu F; García-Pagán J C; Jiménez W; Arroyo V; Bosch J; Rodés J
Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites.
Hepatology (Baltimore, Md.) 1994;20(1 Pt 1):30-3.
-
1994: García-Pagán J C; Feu F; Luca A; Fernández M; Pizcueta P; Bosch J; Rodés J
Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
Journal of hepatology 1994;20(6):792-6.
-
1994: García-Pagán J C; Salmerón J M; Feu F; Luca A; Ginés P; Pizcueta P; Claria J; Piera C; Arroyo V; Bosch J
Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis.
Hepatology (Baltimore, Md.) 1994;19(5):1095-9.
-
1994: García-Pagán J C; Feu F; Castells A; Luca A; Hermida R C; Rivera F; Bosch J; Rodés J
Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1994;19(3):595-601.
-
1993: Feu F; Bordas J M; Luca A; García-Pagán J C; Escorsell A; Bosch J; Rodés J
Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1993;18(5):1082-9.
-
1993: Fernández M; Pizcueta P; García-Pagán J C; Feu F; Cirera I; Bosch J; Rodés J
Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Hepatology (Baltimore, Md.) 1993;18(2):389-93.
-
1993: Salmerón J M; Ruiz del Arbol L; Ginès A; García-Pagán J C; Ginès P; Feu F; Claria J; Rivera F; Bosch J; Arroyo V
Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
Hepatology (Baltimore, Md.) 1993;17(5):800-6.
-
1993: Navasa M; Feu F; García-Pagán J C; Jiménez W; Llach J; Rimola A; Bosch J; Rodés J
Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1993;17(3):355-60.
-
1993: Carreras E; Grañena A; Navasa M; Bruguera M; Marco V; Sierra J; Tassies M D; García-Pagán J C; Martí J M; Bosch J
On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease.
Annals of hematology 1993;66(2):77-80.
-
1993: Panés J; Bordas J M; Piqué J M; García-Pagán J C; Feu F; Terés J; Bosch J; Rodés J
Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy.
Hepatology (Baltimore, Md.) 1993;17(2):213-8.
-
1993: Carreras E; Grañena A; Navasa M; Bruguera M; Marco V; Sierra J; Tassies M D; García-Pagán J C; Martí J M; Bosch J
Transjugular liver biopsy in BMT.
Bone marrow transplantation 1993;11(1):21-6.
-
1993: Luca A; Cirera I; García-Pagán J C; Feu F; Pizcueta P; Bosch J; Rodés J
Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis.
Gastroenterology 1993;104(1):222-7.
-
1993: Bosch J; García-Pagán J C; Feu F; Luca A; Fernández M; Pizcueta P; Rodés J
New approaches in the pharmacologic treatment of portal hypertension.
Journal of hepatology 1993;17 Suppl 2():S41-5.
-
1992: Panés J; Bordas J M; Piqué J M; Bosch J; García-Pagán J C; Feu F; Casadevall M; Terés J; Rodés J
Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy.
Gastroenterology 1992;103(6):1875-82.
-
1992: Bosch J; Pizcueta M P; Fernández M; Feu F; Cirera I; Luca A; García-Pagán J C
Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
Baillière's clinical gastroenterology 1992;6(3):425-36.
-
1992: La Villa G; Salmerón J M; Arroyo V; Bosch J; Ginés P; García-Pagán J C; Ginés A; Asbert M; Jiménez W; Rivera F
Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.
Gastroenterology 1992;102(6):2114-9.
-
1992: García-Pagán J C; Navasa M; Rivera F; Bosch J; Rodés J
Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis.
Gastroenterology 1992;102(6):2015-23.
-
1992: Lacy A M; Navasa M; Gilabert R; Brú C; García-Pagán J C; García-Valdecasas J C; Grande L; Feu F; Fuster J; Terés J
Long-term effects of distal splenorenal shunt on hepatic hemodynamics and liver function in patients with cirrhosis: importance of reversal of portal blood flow.
Hepatology (Baltimore, Md.) 1992;15(4):616-22.
-
1992: Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán J C
Pathophysiology of portal hypertension.
Gastroenterology clinics of North America 1992;21(1):1-14.
-
1991: Pizcueta M P; García-Pagán J C; Fernández M; Casamitjana R; Bosch J; Rodés J
Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.
Gastroenterology 1991;101(6):1710-5.
-
1991: Ruiz del Arbol L; García-Pagán J C; Feu F; Pizcueta M P; Bosch J; Rodés J
Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.
Journal of hepatology 1991;13(2):179-86.
-
1991: García-Pagán J C; Feu F; Bosch J; Rodés J
Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
Annals of internal medicine 1991;114(10):869-73.
-
1991: Ponz E; García-Pagán J C; Bruguera M; Bruix J; Rodés J
Hepatic fibrin-ring granulomas in a patient with hepatitis A.
Gastroenterology 1991;100(1):268-70.
-
1990: García-Pagán J C; Feu F; Navasa M; Bru C; Ruiz del Arbol L; Bosch J; Rodés J
Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
Journal of hepatology 1990;11(2):189-95.
-
1989: Bosch J; Groszmann R J; García-Pagán J C; Terés J; García-Tsao G; Navasa M; Mas A; Rodés J
Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial.
Hepatology (Baltimore, Md.) 1989;10(6):962-8.
-
1989: Ruiz del Arbol L; García-Pagán J C; Feu F; Navasa M; Bosch J
Indocyanine-green: infusion rate and reactions.
Annals of internal medicine 1989;110(10):844-5.
-
1988: García Pagán J C; Piqué J M; Monteagudo J; Feu F; Rives A
[Massive lower gastrointestinal hemorrhage caused by cytomegalovirus colitis in a hemophiliac patient with acquired immunodeficiency syndrome]
Medicina clínica 1988;91(19):741-3.
-
1988: Bosch J; Navasa M; Kravetz D; Pizcueta M P; García-Pagán J C; De Lacy A M; Rodés J
Diagnosis and evaluation of portal hypertension.
Zeitschrift für Gastroenterologie 1988;26 Suppl 2():8-14.
-
1988: Bosch J; Bordas J M; Mastai R; Kravetz D; Navasa M; Chesta J; Pizcueta M P; García-Pagán J C; Rodés J
Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure.
Hepatology (Baltimore, Md.) 1988;8(4):861-5.
-
1988: García-Pagán J C; Bordas J M; Saperas E; Mondelo F; Calvet X; Rodés J
[Efficacy of laparoscopy in the diagnosis of ascites of indeterminate origin]
Medicina clínica 1988;90(7):269-71.
Sign-in to see more
